Decoy Therapeutics is trading 5.61% higher at $1.13 in pre-market, with no specific catalyst confirmed.
- No company-specific announcement explaining the November 2 move was identified in available search results; listed company news was from earlier dates.
- U.S. futures and major indices were higher in the supplied market context, but available evidence does not establish that broader sentiment caused the move.